Patient-centered outcomes in the acute treatment of migraine: a prospective, real-world, longitudinal survey study (UNIVERSE II) comparing migraine patients who switch from a prior triptan to another triptan or ubrogepant. [PDF]
Lipton RB +7 more
europepmc +1 more source
Lin Li,* Guangqi An,* Fuzhen Li,* Donghui Zhang, Xinyue Zhu, Chunyu Liang, Yu Zhao, Kunpeng Xie, Pengyi Zhou, Haiyan Zhu, Xuemin Jin,* Liping Du* Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University ...
Li L +11 more
doaj
Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications. [PDF]
Antanaitytė A +3 more
europepmc +1 more source
Acute migraine treatments in patients above age 65. [PDF]
Shah T +3 more
europepmc +1 more source
Emerging pharmacological targets in migraine therapy: CGRP and beyond. [PDF]
Atraszkiewicz D, Dahiya D.
europepmc +1 more source
Clinical improvement following an integrative iboga microdosing protocol in post-concussive and hypoxic brain injury syndromes: a case series. [PDF]
Tabaac BJ, Carhart-Harris RL, Yung T.
europepmc +1 more source
A 2-Part, Open-Label, Phase 1 Bioequivalence and Food-Effect Study of Ubrogepant in Healthy Adult Participants. [PDF]
Boinpally R, Trugman JM.
europepmc +1 more source
Cryoneurolysis of auriculotemporal nerve for treatment of otalgia. [PDF]
Patel N, Rabiei S, Moon D, Sergeyenko Y.
europepmc +1 more source
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial. [PDF]
Goadsby PJ +9 more
europepmc +1 more source

